T-MAXIMUM
T-Maximum develops CAR-T cell therapies for the treatment of brain tumors. T-Maximum's gene-editing allogeneic immune cell therapy adopts the version 3.0 program with completely independent intellectual property rights to realize allogeneic universal CAR-T therapy and solve the risk of graft-versus-host disease and rejection of allogeneic immune cells.
T-MAXIMUM
Industry:
Biotechnology Health Care Product Research
Founded:
2017-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.t-maximum.com
Status:
Active
Contact:
400-9600-652
Email Addresses:
[email protected]
Total Funding:
0
Investors List
Hongfeng Investment Management
Hongfeng Investment Management investment in Angel Round - T-Maximum
Haibang Capital
Haibang Capital investment in Angel Round - T-Maximum
Official Site Inspections
http://www.t-maximum.com
- Host name: 47.238.209.36
- IP address: 47.238.209.36
- Location: San Mateo United States
- Latitude: 37.5517
- Longitude: -122.33
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94402
More informations about "T-Maximum"
About Us - T-MAXIMUM
We are a company developing allogeneic CAR-T cells to treat refractory diseases represented by advanced solid tumors. We believe that compared with small molecule chemical drugs and large molecule biological drugs, cell drugs have …See details»
Home - T-MAXIMUM
ABOUT US Developing allogeneic CAR-T cells for refractory diseases Repairing and controlling genes in cells or replacing missing or damaged cells can solve the underlying cause of many diseases. These emerging capabilities will create …See details»
T-MAXIMUM Biopharmaceuticals (Suzhou) Co., Ltd.
Explore T-MAXIMUM Biopharmaceuticals (Suzhou) Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 2 news, Disease Domain:Neoplasms, Hemic and …See details»
T-Maximum Company Profile 2024: Valuation, Funding
T-Maximum General Information Description. Developer of CAR-T Cell therapies intended to treat brain tumors. The company has a unique universal CAR-T development platform, …See details»
T-Maximum - Funding, Financials, Valuation & Investors
Aug 20, 2021 T-Maximum develops CAR-T cell therapies for the treatment of brain tumors. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. …See details»
What We Do - T-MAXIMUM
At T-MAXIMUM, we are at the vanguard of developing allogeneic CAR-T therapies, unlocking the vast therapeutic potential of engineered T cells to revolutionize the treatment of refractory …See details»
T-Maximum - Crunchbase
T-Maximum develops CAR-T cell therapies for the treatment of brain tumors.See details»
WuXi ATU and T-MAXIMUM Announce Strategic …
June 6, 2023 – Boston, Massachusetts. WuXi Advanced Therapies (WuXi ATU), a global Contract Testing, Development and Manufacturing Organization (CTDMO), and T-MAXIMUM today signed a strategic collaboration …See details»
MT-026 (T-Maximum) - Drug Targets, Indications, Patents
Nov 21, 2024 The goal of this clinical trial is to estimate the safety, tolerance and initial efficacy of target IL-13Rα2 or B7-H3 UCAR-T cell injection in the treatment of patients with advanced …See details»
Contact us - T-MAXIMUM
We are a company developing allogeneic CAR-T cells to treat refractory diseases represented by advanced solid tumors. Ningbo, Suzhou, ChongqingHong Kong, United States INVEST@t …See details»
药明生基与茂行生物就通用型CAR-T产品达成战略合作
Jun 9, 2023 WuXi ATU and T-MAXIMUM Announce Strategic Partnership of Cooperation for MT-027 UCAR-T. June 6, 2023. Boston, Massachusetts. WuXi Advanced Therapies (WuXi …See details»
Home - T-Maximus
T-Maximus Delivers ExceptionalIT & Non IT Staffing Solutions The dynamic and fastest-growing recruitment company in India, T-Maximus is a customer-centric organization going beyond …See details»
药明生基与茂行生物就通用型CAR-T产品达成战略合作｜Bilingual …
Jun 9, 2023 药明康德内容团队编辑日前，药明生基与茂行生物美国公司T-MAXIMUM Pharmaceutical（简称：T-MAXIMUM）共同宣布达成战略合作协议。药明生基将为茂行生物 ...See details»
What is division org and how do I increase it? (New Player ... - Reddit
Your division's organization value is technically it's maximum organization value. When you look at your templates and see a number, that is their maximum amount of org. Your unit's …See details»
T-Maximum - Tech Stack, Apps, Patents & Trademarks - Crunchbase
T-Maximum develops CAR-T cell therapies for the treatment of brain tumors.See details»
T-Maximum - Updates, News, Events, Signals & Triggers
T-Maximum develops CAR-T cell therapies for the treatment of brain tumors.See details»
Maximum Fun Production Fellow, 2025-2026 | Maximum Fun
Maximum Fun Production Fellow, Winter 2025-2026. Maximum Fun is an employee-owned independent podcast and radio production organization, based in Los Angeles. The network …See details»
Publication - T-MAXIMUM
01 2023-06 2023 ASCO E-POSTER 02 2022-09 2022 ESMO-MT026 03 2022-09 2022 ESMO-MT027See details»
Telecom - T-Maximus
Home Industry Verticals Telecom Telecom Telecom Excellence with T-Maximus The telecommunications industry has been the epicenter of profound transformation in the last …See details»